38 results
Page 2 of 2
8-K
EX-99.1
971sl2
10 May 22
Rallybio Reports First Quarter 2022 Financial Results
4:01pm
DEF 14A
wye520924b6xgubendx
25 Apr 22
Definitive proxy
5:03pm
8-K
EX-99.1
kcnvcoghvmo he
4 Apr 22
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
8:35am
10-K
9x9xii9 za2er3s
15 Mar 22
Annual report
4:31pm
8-K
EX-99.1
i6a1dn7i4h4u0du3k71s
7 Mar 22
MARCH 2022 TAKING A DEVASTATING DISEASE – AND DEVASTATING IT. We’re going there. Corporate Presentation
8:00am
8-K
EX-99.1
qjn5si3o7sm
10 Nov 21
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
7:32am
10-Q
rgahc 8wr30kg
9 Sep 21
Quarterly report
4:16pm
424B4
prl9ipy
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
mjgt6c1pwh3w914
22 Jul 21
IPO registration (amended)
4:04pm
S-1
e49csy6h9rcv8 vtuufo
2 Jul 21
IPO registration
4:28pm
S-1
EX-10.6
0ey0lddkgns9p
2 Jul 21
IPO registration
4:28pm
DRS/A
EX-10.6
60cq8xttn3i42sx
7 Jun 21
Draft registration statement (amended)
12:00am
DRSLTR
m7fsqq cm
7 Jun 21
Correspondence regarding draft registration statement
12:00am
DRS/A
iru64ztfa a69mgvf9op
7 Jun 21
Draft registration statement (amended)
12:00am
UPLOAD
8411fnsdli8cxnfkbmg
24 May 21
Letter from SEC
12:00am
DRS
rjhm4m07645
27 Apr 21
Draft registration statement
12:00am